- Conditions
- Periprosthetic Joint Infections
- Interventions
- EP Granules with Tobramycin, empty voids
- Device
- Lead sponsor
- Elute, Inc.
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 204 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2025
- U.S. locations
- 12
- States / cities
- Los Angeles, California • Skokie, Illinois • Indianapolis, Indiana + 8 more
Source: ClinicalTrials.gov public record
Updated Jan 7, 2025 · Synced May 22, 2026, 4:15 AM EDT